PT  - JOURNAL ARTICLE
AU  - Fraga-Iriso, Rebeca
AU  - Amor-Carro, Óscar
AU  - Brienza, Nadia S.
AU  - Núñez-Naveira, Laura
AU  - Lema-Costa, Beatriz
AU  - González-Barcala, Francisco Javier
AU  - Bazús-González, Teresa
AU  - Montero-Martínez, Carmen
AU  - López-Viña, Antolín
AU  - Torrego, Alfons
AU  - Plaza, Vicente
AU  - Martínez-Rivera, Carlos
AU  - Hamid, Qutayba
AU  - Martin, James G.
AU  - Berger, Patrick
AU  - Ramos-Barbón, David
TI  - Contractile cell apoptosis regulates airway smooth muscle remodeling in asthma
AID  - 10.1101/2021.02.08.21251269
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.08.21251269
4099  - http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251269.short
4100  - http://medrxiv.org/content/early/2021/02/10/2021.02.08.21251269.full
AB  - Rationale Investigations on the mechanisms of airway smooth muscle remodeling, a prominent asthma feature contributing to its clinical manifestations and severity, have largely focused on its hyperplastic growth. Conversely, limited data and virtually no translational research have been produced on a plausible role of apoptosis in the homeostasis and remodeling of airway smooth muscle.Objectives We aimed at demonstrating an involvement of apoptosis, an essential regulator of organ structure and cell turnover, in the pathophysiology of airway smooth muscle remodeling in asthma.Methods Murine experimental asthma was modeled to analyze airway hyperresponsiveness, contractile tissue remodeling and apoptosis detection outcomes at early and late cutoffs, and under pharmacological inhibition of apoptosis by employing a caspase blocker. Clinical investigation followed through analyses on human bronchial biopsies.Results Airway hyperresponsiveness and contractile tissue remodeling were already established in early experimental asthma, and a subsequent upregulation of apoptosis limited the airway contractile tissue growth. Caspase inhibition elicited chaotic pulmonary mechanics and an unusual growth of airway smooth muscle that was structurally disorganized. In bronchial biopsies, airway smooth muscle increased from controls through subjects with intermittent and persistent moderate and severe asthma. Cleaved poly-ADP ribose polymerase (c-PARP, a byproduct of caspase activity) was increased in severe asthma.Conclusions Apoptosis is involved in airway contractile cell turnover and in shaping the size, structure and proper function of the airway smooth muscle layer. Apoptosis inhibitors may complicate concomitant asthma, whereas agents favouring airway contractile cell apoptosis may provide a novel pipeline of therapeutic development.Key messagesHow normal airway smooth muscle structure is preserved, and whether counteracting responses to remodeling are elicited in asthma, are outstanding questions not probed in vivo nor in the clinical setting.In this work, combined investigations on murine experimental asthma and human bronchial biopsies show that airway contractile cell apoptosis is involved in the homeostasis of airway smooth muscle, and apoptotic activity is upregulated as part of the remodeling process of this tissue in asthma.Apoptosis arises as a key regulator of the size and structure of the airway smooth muscle layer. This concept draws implications for clinical practice and drug development.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Fondo de Investigación Sanitaria (FIS, Instituto de Salud Carlos III, Government of Spain & European Regional Development Fund) and the Sociedad Española de Neumología y Cirugía Torácica (SEPAR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board of Hospital de la Santa Creu i Sant Pau, Barcelona, as a central ethics committee. The Biobank Subspecialized in Bronchial Biopsy for Asthma Research is a collection hosted as part of an institutional biobank at the Biomedical Research Institute of the Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, with registration B.0000722 at the National Registry of Biobanks (Instituto de Salud Carlos III, Government of Spain), in compliance with Law 14/2007 on Biomedical Research.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll numerical data backing the results are summarized in the online data supplement accompanying this preprint. Raw databases are available upon request after publication in a peer-reviewed journal.